Aims

  • to provide a simple, best guess approach to the treatment of common infections
  • to promote the safe, effective and economic use of antibiotics
  • to minimise the emergence of bacterial resistance in the community

  Principles of Treatment

  1. This guidance is based on the best available evidence but its application must be modified by professional judgement.
  2. Prescribe an antibiotic only when there is likely to be a clear clinical benefit
  3. Do not prescribe an antibiotic for viral sore throat, simple coughs and colds.
  4. Limit prescribing over the telephone to exceptional cases.
  5. Use simple generic antibiotics first whenever possible.
  6. The use of new and more expensive antibiotics (eg quinolones and cephalosporins) is inappropriate when standard and less expensive antibiotics remain effective
  7. Avoid widespread use of topical antibiotics (especially those agents also available as systemic preparations).
  8. In pregnancy AVOID tetracyclines, aminoglycosides, quinolones, high dose metronidazole. Short-term use of trimethoprim (theoretical risk in first trimester in patients with poor diet, as folate antagonist) or nitrofurantoin (at term, theoretical risk of neonatal haemolysis) is unlikely to cause problems to the foetus.
  9. Clarithromycin is an acceptable alternative in those who are unable to tolerate erythromycin because of side effects.
  10. Where a ‘best guess’ therapy has failed or special circumstances exist, microbiological advice can be obtained from Consultant Microbiologists Dr De or Dr Pillay 

 

IllnessDose

Comments

Drug

Duration
of Tx

UPPER RESPIRATORY TRACT INFECTIONS: Consider delayed antibiotic prescriptions.A-

Influenza

Influenza

Annual vaccination is essential for all those at risk of influenza. For otherwise healthy adults, antivirals are not recommended. Treat ‘at risk’ patients, only when influenza is circulating in the community (notification by Public Health email), within 48 hours of onset. At risk: 65 years or over, chronic respiratory disease (including COPD and asthma) significant cardiovascular disease (not hypertension), immunocompromised, diabetes mellitus, chronic renal disease. Patients over 12 years use oseltamivir 75 mg oral capsule BD (for OD prophylaxis see Influenza ) or zanamivir 10 mg (2 inhalations by diskhaler) BD for 5 days.

Pharyngitis /

sore throat / tonsillitis

Prodigy

SIGN

The majority of sore throats are viral; most patients do not benefit from antibiotics. Patients with 3 of 4 centor criteria (history of fever, purulent tonsils, cervical adenopathy, absence of cough) or history of otitis media may benefit more from antibiotics.A- Antibiotics only shorten duration of symptoms by 8 hours.A+ NNT = 30 (child) or 145 (adult) to prevent one case of otitis media.A+ Seven days treatment gives less relapse than three days.B+

Recent evidence indicates that penicillin 500 mg TDS for 7 days is more effective than 3 days.B+ Twice daily higher dose can also be used.A- QDS may be more appropriate if severe.D

phenoxymethylpenicillin first line

500 mg BD-QDS

7-10 days

erythromycin

if allergic to penicillin

500 mg BD or

250 mg QDS

(QDS less side-effects)

5-10 days

Otitis media

(child doses)

Many are viral. Resolves in 80% without antibiotics.A+ Poor outcome unlikely if no vomiting or temp <38.5oC.A- Use NSAID or paracetamol.A- Antibiotics do not reduce pain in first 24 hours, subsequent attacks or deafness.A+ NNT = 20 (>2y) and NNT = 7 (6-24m old) to get pain relief in one at 2-7 days.A+B+

amoxicillin

first line

<2 yrs 125 mg TDS

2-10 yrs 250 mg TDS

>10 yrs 500 mg TDS

3-7 days*

3-7 days*

3-7 days*

Prodigy

erythromycin

if allergic to penicillin

 

Azithromycin

2nd line if allergic to penicillins

co-amoxiclav

2nd line

<2 yrs 125 mg QDS

2-8 yrs 250 mg QDS

Other: 250-500 mg QDS

15-25kg 200 mg OD

26-35kg 300 mg OD

36-45kg 400 mg OD

1-6 yrs 156 mg TDS

6-12 yrs 312 mg TDS

3-7 days*

3-7 days*

3-7 days*

3 days

3 days

3 days

3-7 days*

3-7 days*

Rhinosinusitis

acute or chronic

Prodigy

Many are viral. Symptomatic benefit of antibiotics is small - 69% resolve without antibiotics; and 84% resolve with antibiotics.A+ Reserve for severeB+ or symptoms (>10 days).

Cochrane review concludes that amoxicillin A+ and phenoxymethylpenicillin A+ have similar efficacy to the other recommended antibiotics.

phenoxymethylpenicillin

or amoxicillin

or oxytetracycline

or erythromycin

or doxycycline

500 mg TDS

500 mg TDS

250 mg QDS

250 mg QDS/500mg BD

200 mg stat/100 mg OD

7-10 days

7-10 days

7-10 days

7-10 days

7-10 days

If failure to respond to first line antibiotics

co-amoxiclav

625 mg TDS

7-10 days

Laryngitis/ laryngtracheo bronchitis

Caused by respiratory virus

No antibiotic treatment

* Standing Medical Advisory Committee guidelines suggest 3 days. In otitis media, relapse rate is slightly higher at 10 days with a 3 day course but long-term 
outcomes are similar.A+.

LOWER RESPIRATORY TRACT INFECTIONS

Note: Avoid tetracyclines in pregnancy. Low doses of penicillins are more likely to select out resistance. The quinolones ciprofloxacin and ofloxacin have poor activity against pneumococci. However, they do have use in PROVEN pseudomonal infections. Levofloxacin has some anti-Gram-positive activity but should not be needed as first line treatment.

Acute bronchitis

Prodigy

Systematic reviews indicate antibiotics have

marginal benefits in otherwise healthy adults.A+

onsider antibiotics in > 60 yrs or if underlying chest disease. Patient leaflets can reduce antibiotic use.B+

amoxicillin

or oxytetracycline

or doxycycline

500 mg TDS

250–500 mg QDS

200 mg stat/100 mg OD

5 days

5 days

5 days

Acute

exacerbation of COPD

NICE

30% viral, 30-50% bacterial

Antibiotics not indicated in absence of purulent/mucopurulent sputum.B+ Most valuable if increased dyspnoea and increased purulent sputum.B+ In penicillin allergy use

erythromycin if tetracycline contraindicated

If clinical failure to first line antibiotics

amoxicillin

or oxytetracycline

or doxycycline

erythromycin

co-amoxiclav

500 mg TDS

250 mg QDS

200 mg stat/100 mg OD

250 – 500 mg QDS

625 mg TDS

5-10 days

5-10 days

5-10 days

5-10 days

5-10 days

Community-acquired pneumonia -

treatment in the community

BTS

BTS pdf

Start antibiotics immediately.B- If no response in 48 hours consider admission or add erythromycin first line or a tetracyclineC to cover Mycoplasma infection (rare in over 65s)

In severely ill give parenteral benzylpenicillin before admissionC and seek risk factors for Legionella and Staph. aureus infection.D

  • Sputum examination is not recommended after starting antibiotics
  • If post influenzal, consider adding flucloxacillin (500mg qds) or co-amoxiclav

amoxicillin

and / or erythromycin

500 mg - 1g TDS

500 mg QDS

Up to 10 days

Up to 10 days

oxytetracycline

or doxycycline

250-500 mg QDS

200 mg stat/100 mg OD

Up to 10 days

Up to 10 days

MENINGITIS

Suspected meningococcal disease

HPA HPA pdf

Transfer all patients to hospital immediately. Administer benzylpenicillin prior to admission, unless history of anaphylaxis,B- NOT allergy. Ideally IV but IM if a vein cannot be found.

IV or IM benzylpenicillin

 

 

 

If allergic to penicillin

Chloramphenicol

 

 

 

 

Ceftriaxone IV

Adults and children

10 yr and over: 1200 mg

Children 1 - 9 yr: 600 mg

Children <1 yr: 300 mg

 

Adults: 50 to 100 mg / kg

Children > 1yr: 12.5 to 25mg / kg

Children 2 wks to 1 yr: 12.5 mg / kg

Infants < 2 wks: 6mg / kg

Adult: 2g

Neonate: 20-50mg/kg

Infant & child under 50kg: 20-50mg/kg

Over 50kg: adult dose

 

 

 

 

 

 

 

 

 

 

 

 

 

Prevention of secondary case of meningitis:

  • Only prescribe following advice from Public Health Doctor: 9 am – 5 pm: Birmingham and Solihull Health Protection Unit

  • 0121 224 4670

  • Out of hours: Contact on-call Public Health doctor via Heartlands switchboard

  • 0121 424 2000

  • URINARY TRACT INFECTIONS UTI quick reference guide ESBL Prodigy

    Note:. Amoxicillin resistance is common, therefore ONLY use if culture confirms susceptibility. In the elderly (>65 years), do not treat asymptomatic bacteriuria.
    In the presence of a catheter, antibiotics will not eradicate bacteriuria; only treat if systemically unwell or pyelonephritis likely.

    Uncomplicated UTI ie no fever or flank pain

    Use urine dipstick to exclude UTI -ve nitrite and leucocyte 95% negative predictive value.

    Multi-resistant E. coli with ESBLs are increasing so perform culture in all treatment failures. There is less relapse with trimethoprim than cephalosporins or quinolonesA-

    trimethoprimB+

    or nitrofurantoinA-

    200 mg BD

    50-100 mg QDS

    3 daysB+

    7 daysC in

    elderlyC

    UTI quick reference guide

    2nd line - depends on susceptibility of organism isolated eg nitrofurantoin

    amoxicillin, cefalexin, co-amoxiclav, quinolone

    ESBLs are multi-resistant but some remain sensitive to nitrofurantoin

    UTI in pregnancy and men

    Send MSU for culture. Short-term use of trimethoprim (avoid 1st trimester) or nitrofurantoin (avoid third trimester, at term) in pregnancy is unlikely to cause problems to the foetus.B+

    nitrofurantoin

    or trimethoprim

    2nd line

    cefalexin

    or co-amoxyclav

    50 mg – 100 mg QDS

    200 mg BD

    500 mg BD

    375 mg TDS

    7 days

    7 days

    7 days

    7 days

    Catheter UTI

    Only treat if systemic signs or symptoms of infection

    Bacterial eradication is not a realistic goal

    Consider whether catheter is clinically essential

    Co-amoxiclav

    1st line

    2nd line depends on sensitivity

    375mg TDS

    5 days

    Children

    Send MSU for culture and susceptibility.

    Waiting 24 hours for results is not detrimental to outcome.A-

    trimethoprim

    or nitrofurantoin

    or cefalexin

    If susceptible, amoxicillin

    See BNF for dosage

    7 daysA+

    Acute pyelonephritis

    Send MSU for culture. A recent RCT showed 7 days ciprofloxacin was as good as 14 days co-trimoxazole.A-

    If no response within 24 hours admit.

    ciprofloxacinA-

    or co-amoxiclav

    If susceptible, trimethoprim

    500 mg BD

    500/125 mg TDS

    200 mg BD

    7 daysA-

    14 days

    14 days

    Recurrent UTI women ≥ 3/yr

    Post coital prophylaxis is as effective as prophylaxis taken nightly. Prophylactic doses

    nitrofurantoin

    or trimethoprim

    50 mg

    100 mg

    Stat post coital or od at night

    GASTRO-INTESTINAL TRACT INFECTIONS

    Eradication of Helicobacter pylori

    NICE

    Helicobacter quick reference guide

     

    Managing symptomatic relapse

    Eradication is beneficial in DU, GU and low grade MALTOMA, but NOT in GORD.A In NUD, 8% of patients benefit.

    Triple treatment attains >85% eradication.A+

    Avoid clarithromycin or metronidazole if used in the past year for any infection.C

    DU/GU: Retest for helicobacter if symptomatic

    NUD: Do not retest, treat as functional dyspepsia

    In treatment failure consider endoscopy for culture & susceptibility.C Substitute oxytetracycline for clarithromycin or metronidazole and add bismuth salt.A-

    First lineA+ cheapest option

    lansoprazole

    PLUS metronidazole

    AND clarithromycin

    Alternative regimens A+

    PPI OR

    ranitidine bismuth citrate

    PLUS 2 antibiotics:

    amoxicillin

    clarithromycinA+

    metronidazole

    oxytetracycline

    30 mg BD

    400 mg BD

    250 mg BD

     

    BD

    400 mg BD

    1 g BD

    500 mg BD

    400 mg BD

    500 mg QDS

     

     

    All for

    7 daysA

    14 days in relapse or maltoma

     

     

     

     

    Gastroenteritis

    Prodigy

    Fluid replacement essential. Antibiotic therapy is not usually indicated as it only reduces diarrhoea by 1-2 daysB+ and can cause antibiotic resistance.B+ Initiate treatment, on advice of microbiologist, if the patient is systemically unwell. Please send stool specimens from suspected cases of food poisoning. Notify and seek advice on exclusion of patients from, Public Health Doctor ( as above

    Traveller’s diarrhoea

    Limit prescription of antibacterial to be carried abroad and taken if illness develops (ciprofloxacin 500 mg single dose) to people travelling to remote areas and for people in whom an episode of infective diarrhoea could be dangerous.

    GASTRO-INTESTINAL TRACT INFECTIONS (Continued)

    Threadworms

    Prodigy

    Treat household contacts. Advise morning shower/baths and hand hygiene.

    Use piperazine in children under 2.

    Do not withhold from school

    mebendazole

    or piperazine

    100 mg

    1-6 yrs 5ml spoon

    3-12 mths 2.5ml spoon

    stat

    stat, repeat after 2 weeks

    Antibiotic associated diarrhoea

    Send stool sample for Clostridium difficile toxin testing

    metronidazole

    400mg TDS

    10 days

    Dysentry

    Send stool sample for testing. If history of recent travel, add in metronidazole

    ciprofloxacin

    500mg BD

    5 days

    GENITAL TRACT INFECTIONS – UK NATIONAL GUIDELINES Vaginal discharge quick reference guide BASHH

    Note: Refer patients with risk factors for STIs (<25y, no condom use, recent (<12mth) or frequent change of sexual partner, previous STI, symptomatic partner) to GUM clinic or general practices with level 2 or 3 expertise in GUM.

    Vaginal candidiasis

    All topical and oral azoles give 80-95% cure.A-

    In pregnancy avoid oral azole.B

    In complicated cases (diabetes, recurrence or severe cases) send sample for culture and treat 7-14 days

    clotrimazole 10%

    or clotrimazole

    or fluconazole

    5 g vaginal cream

    500 mg pessary

    150 mg orally

    stat

    stat

    stat

    Bacterial vaginosis

    A 7 day course of oral metronidazole is slightly more effective than 2 g stat.A+

    Avoid 2g stat dose in pregnancy.

    Topical treatment gives similar cure ratesA+ but is more expensive.

    metronidazoleA+

    or metronidazole

    0.75% vag gelA+

    or clindamycin 2% creamA+

    400 mg BD

    5 g applicatorful at night

    5 g applicatorful at night

    7 days

    5 days

    7 days

    Chlamydia trachomatis

    Chlamydia quick reference guide

    Tetracyclines are contra-indicated in

    pregnancy.

    Erythromycin and ciprofloxacin are less efficacious than doxycycline.

    Treat partners

    Refer contacts to GUM clinic

    doxycyclineA+

    or oxytetracyclineA-

    erythromycin A-

     

    azithromycinA+

    100 mg BD

    500 mg QDS

    500 mg BD

    or 500 mg QDS

    1 g stat

    7 days

    7 days

    14 days

    7 days

    1 hr before or

    2 hrs after food

    Trichomoniasis

    Refer to GUM. Treat partners simultaneously

    In pregnancy avoid 2g single dose metronidazole. Topical clotrimazole gives symptomatic relief (not cure).

    metronidazoleA-

     

    clotrimazole

    400 mg BD

    or 2 g in single dose

    100 mg pessary

    5-7 days

     

    6 days

    Pelvic Inflammatory Disease

    (PID)

    Essential to test for N. gonorrhoea (as increasing antibiotic resistance) and chlamydia.

    Microbiological and clinical cure are

    greater with ofloxacin than with doxycycline.A+

    Refer contacts to GUM clinic

    metronidazole +

    ofloxacinB

    or

    metronidazole +

    doxycyclineB

    400 mg BD

    400 mg BD

    400 mg BD

    100 mg BD

    14 days

    14 days

    14 days

    14 days

    Acute prostatitis

    4 weeks treatment may prevent chronic infection.

    Quinolones are more effective.

    ciprofloxacin

    or trimethoprimC

    500 mg BD

    200 mg BD

    28 days

    28 days

    Urethritis

    Refer with partners to GUM

    Doxycycline

    First line

     

    Ciprofloxacin +

    Azithromycin

    100mg BD

     

     

    500mg

    1g

    7 days

     

     

    stat

    stat

    Epididymitis

    A) Younger patient (< 35 years). Exclude sexually transmitted epididymitis (Chlamydia / Gonorrhoea) even in the absence of urethral discharge. Diagnosis and treatment (also partners) should be best managed by GUM referral.

    B) Older Patient (> 35 years). Underlying urological pathology common. Non-specific bacterial infections with coliforms, Pseudomonas,eneterococcus. May develop after urinary tract surgery or catheterisation. Treat with ciprofloxacin (500mg BD, 5 days) initially. If failure to respond (or develops increasing pain or swelling), infarction,abscess or pyocoele should be suspected warranting urgent referral to urology.

    SKIN / SOFT TISSUE INFECTIONS

    Impetigo

    Prodigy

     

     

    Systematic review indicates topical and oral treatment produces similar resultsA+

    As resistance is increasing reserve topical antibiotics for very localised lesionsC or D Reserve Mupirocin for MRSA.

    flucloxacillin First

    or erythromycin line

    fusidic acid

    mupirocin

    Oral 500 mg QDS

    Oral 500 mg QDS

    Topically QDS

    Topically QDS

    7 days

    7 days

    5 days

    5 days

    Eczema

    Prodigy

    Using antibiotics, or adding them to steroids, in eczema does not improve healing unless there are visible signs of infection.

    Cellulitis

    In mild cellulitis flucloxacillin maybe used as single drug treatment.C Refer severe cases to consultant microbiologist

    In facial cellulitis use co-amoxiclavC

    In sacral or chronic wound associated cellulitis, add metronidazole

    flucloxacillin

    OR erythromycin alone

     

    co-amoxiclav

    500 mg QDS

    500 mg QDS

     

    500/125 mg TDS

    7 – 14 days

    7 – 14 days

     

    7 - 14 days

    Leg ulcers

    Prodigy

    Bacteria will always be present. Antibiotics do not improve healing.A+ Culture swabs and antibiotics are only indicated if diabetic or there is evidence of clinical infection such as inflammation/redness/cellulitis; increased pain; purulent exudate; rapid deterioration of ulcer or pyrexia. Sampling for culture requires cleaning then vigorous curettage and/or aspiration.

     

     

    Diabetic leg ulcer

    Refer for specialist opinion if severe infection.

    co-amoxiclav

    625 mg TDS

    7-10 days

    and review

    Animal bite

    Prodigy

     

     

     

    Human bite

    Surgical toilet most important.

    Assess tetanus and rabies risk.

    Antibiotic prophylaxis advised for – puncture wound; bite involving hand, foot, face, joint, tendon, ligament; immunocompromised, diabetics, elderly, asplenic

    Antibiotic prophylaxis advised.

    Assess HIV/hepatitis B & C risk

    First line animal & human

    prophylaxis and treatment

    co-amoxiclavB-

    If penicillin allergic:

    metronidazole PLUS

    doxycycline

    or oxytetracycline (animal)

    or erythromycin (human)

    and review at 24 & 48 hrs

     

    375-625 mg TDS

     

    200-400 mg TDS

    100 mg BD

    250-500 mg QDS

    250-500 mg QDS

     

    7 days

     

    7 days

    7 days

    7 days

     

     

    Conjunctivitis

    Prodigy

    Most bacterial infections are self-limiting (64% resolve on placeboA+). They are usually unilateral with yellow-white mucopurulent discharge.

    Refer if secondary to trauma or contact lens use

    chloramphenicol

    0.5% drops +

    1% ointment

    fusidic acid

    2 hrly reducing to QDS

    at night

    1% gel BD

     

    All for 48 hours after resolution

    Scabies

    Prodigy

    Treat whole body including scalp, face, neck, ears, under nails. Treat all household contacts.

    permethrinA+

    5% cream

    2 applications one week apart

    Dermatophyte infection of the proximal fingernail or toenail

    For children seek advice

    Take nail clippings

    Idiosyncratic liver reactions occur rarely with terbinafine.

    5% amorolfine nail lacquerB-

    terbinafineA-

    1-2x/weekly fingers

    toes

    250 mg OD fingers

    toes

    6 months

    12 months

    6 – 12 weeks

    3 – 6 months

    Pulsed itraconazole monthly is recommended for infections with yeasts and non-dermatophyte moulds.C

    itraconazole

    200 mg BD fingers

    toes

    7 days monthly

    2 courses

    7 days monthly

    3 courses

    Dermatophyte infection of the skin

    Prodigy

    Take skin scrapings for culture.

    Treatment: 1 week terbinafine is as effective as 4 weeks azole. A-If intractable consider oral itraconazole. Discuss scalp infections with specialist.

    Topical 1% terbinafine A+

    Topical undecenoic acid or 1% azoleA+

    OD - BD

    1-2x/daily

    1 weekA+

    4 – 6 weeksA+

    Herpes zoster/

    Chicken pox

    Prodigy

    &

    Varicella zoster/

    shingles

    If pregnant seek advice re treatment and prophylaxis

    Chicken pox: Clinical value of antivirals minimal unless immunocompromised, severe pain, on steroids, secondary household case AND treatment started <24h of onset of rash.A-

    Shingles: Treatment indicated if: ophthalmic or predictors of post-herpetic neuralgia: >60 yA+, severe pain,A+ severe skin rash, prolonged prodomal painB+ AND <72h of onset of rash.

    aciclovir

    or

    valaciclovir

    800 mg 5x/day

    1 g TDS

    Child doses – see BNF

    7 days

    7 days

     

     

     

     

     

     

    References

    The following references were used when developing these guidelines:

    This guidance was initially developed by practitioners in South Devon, as part of the S&W Devon Joint Formulary Initiative, and Cheltenham & Tewkesbury Prescribing Group and modified by the PHLS South West Antibiotic Guidelines Project Team, PHLS Primary Care Co-ordinators and members of the Clinical Prescribing Sub-group of the Standing Medical Advisory Committee on Antibiotic Resistance. It was further modified following comments from Internet users, and information from systematic reviews as they have been published.

    Grading of guidance recommendations

    The strength of each recommendation is qualified by a letter in parenthesis.

    Study design

    Recommendation
    grade

    Good recent systematic review of studies

    A+

    One or more rigorous studies, not combined

    A-

    One or more prospective studies

    B+

    One or more retrospective studies

    B-

    Formal combination of expert opinion

    C

    Informal opinion, other information

    D

    PRODIGY web http://www.prodigy.nhs.uk. BNF (No 40 September 2000), SMAC report - The path of least resistance (1998), SDHCT Medical Directorate guidelines + GU medicine guidelines, Plymouth Management of Infection Guidelines project LRTI and URTI.

     

     

    UPPER RESPIRATORY TRACT INFECTIONS

    Influenza

    http://www.hpa.org.uk/infections/topics_az/influenza/flu.htm#Influenza

    Oseltamir for influenza. Drug & Therapeutic Bulletin 2002;40:89-91. (Review of benefits of oseltamir in influenza)

    Turner D, Wailoo A, Nicholson K et al. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. University of Leicester 2002.

    Stephanie A. Call, MD, MSPH; Mark A. Vollenweider, MD, MPH; Carlton A. Hornung, PhD, MPH; David L. Simel, MD, MHS; W. Paul McKinney, MD. Does this patient have influenza? JAMA. 2005;293:987-997.

    Pharyngitis/sore throat/tonsillitis

    Centor RM, Whitherspoon JM Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decision Making 1981;1:239-46.

    Del Mar C & Glasziou P. Antibiotics for the symptoms and complications of sore throat. In: The Cochrane Library, Issue 2. 1998 Oxford: Update Software. Search date 1998; primary sources Index Medicus 1945-65. Medline 1966 to 1997; Cochrane Library 1997 Issue 4; hand search of reference lists of relevant articles.

    Del Mar C. Sore throats and antibiotics: Applying evidence on small effects is hard; variations are probably inevitable. Brit Med J 2000;320:130-1.

    Del Mar C & Glasziou P. Upper respiratory tract infections. In: Clinical Evidence Concise. London. BMJ Publishing Group. 2004;11:369-70.

    Lan AJ, Colford JM, Colford JMJ. The impact of dosing frequency on the efficacy of 10 day penicillin or amoxicillin therapy for streptococcal tonsillopharyngitis: A meta-analysis. Pediatr 2000;105(2):E19.

    McIsaac WJ, Goel V, Slaughter PM, Parsons GW, Woolnough KV, Weir PT, Ennet JR. Reconsidering sore throats. Part 2: Alternative approach and practical office tool. Can Fam Physician 1997;43:495-500.

    Prodigy Guidance @ http://www.prodigy.nhs.uk/guidance.asp?gt=Sore%20throat%20-%20acute

    Swart Sjoerd, Sachs APE, Ruijs G, Gubbels JW, Hoes AW, de Melker RA. Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults. Brit Med J 2000;320:150-4.

    Scottish Intercollegiate Guidelines Network. Management of sore throat and indications for tonsillectomy. 1999. http://www.show.scot.nhs.uk/sign/home.htm.

    Interim UK guidelines for public health management of close community contacts of invasive Group A streptococcal disease http://www.hpa.org.uk/infections/topics_az/strepto/guidelines.htm

    Otitis media

    Dagan R, Klugman KP, Craig WA. Baquero F. Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimicrob Chemother 2001;47:129-140. (Discusses penetration of antibiotics in OM)

    Damoiseaux RAMJ, Van Balen FAM, Hoes AW, de Melker RA. Antibiotic treatment of acute otitis media in children under two years of age: evidence based? Brit J Gen Pract 1998;48:1861-4.

    Damoiseaux RAMJ, Van Balen FAM, Hoes AW, Verhiej TJM, de Melker RA. Primary care-based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. Brit Med J 2000;320:350-4.

    Glasziou IP, Del Mar CB, Sanders SC, Hayem M. Antibiotics for acute otitis media in children (Cochrane Review). In: The Cochrane Library 2003. Issue 2. Oxford. Update software.

    Kozyrskj AL, Hildes Ristein E, Longstaffe SEA, Wincott JL, Sitar DS, Klassen TP et al. Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis. JAMA 1998;279:1736-42.

    Little P, Gould C, Williamson I, Moore M, Warner G, Dunleavey J. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ 2001;322:336-42.

    Little P. Gould C, Moore M, Warner G, Dunleavey J. Williamson I. Predictors of poor outcome and benefits from antibiotics in children with acute otitis media: pragmatic randomised trial. BMJ 2002;325:22-26.

    O’Neill P & Roberts R. Acute otitis media. In: Clinical Evidence Concise. London. BMJ Publishing Group 2004;11:47-49

    Rhinosinusitis

    de Ferranti SD, Lonnidis JPA, Lau J, Anniger WV, Barza M. Are amoxicillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. Brit Med J 1998;317:632-7. Search date May 1998; primary sources Medline 1966 – May 1998; manual search of Excerpta Medica: recent abstracts for Interscience Conference on Antimicrobial Agents & Chemotherapy 1993-1997 and references of all trails review articles and special issues for additional studies.

    Del Mar C & Glasziou P. Upper respiratory tract infections. In: Clinical Evidence Concise. London. MBJ Publishing Group 2004;11:369-70.

    Diagnosis and treatment of acute bacterial rhinosinusitis. Summary, Evidence Report/Technology Assessment: Number 9 March 1999. Agency for Health Care Policy & Research, Rockville MD. http://www.ahcpr.gov/clinic/sinussum.htm

    Hansen JG, Schmidt H, Grinsted P. Randomised, double blind, placebo controlled trial of Penicillin V in the treatment of acute maxillary sinusitis in adults in general practice. Scan J Prim Health Care 2000;18:44-47.

    International Rhinosinusitis Advisory Board. Infectious rhinosinusitis in adults. Classification, aetiology and management. Ear Nose & Throat Journal 1997;76 (12 Suppl):1-22.

    Prodigy Guidance @ http://www.prodigy.nhs.uk/guidance.asp?gt=Sinusitis

    Williams Jr JW, Aguilar C, Cornell J, Chiquette E. Dolor RJ, Makela M, Holleman DR, Simel DL. Antibiotics for acute maxillary sinusitis (Cochrane Methodology Review). In: The Cochrane Library, Issue 4, 2003. Chichester, UK: John Wiley & Sons, Ltd.

    http://www.antibioticresistance.org.uk/ARFAQs.nsf/0/44BFE0C0107D0CC380256F350045B0F4?OpenDocument

     

    LOWER RESPIRATORY TRACT INFECTIONS

    Acute bronchitis

    Becker L, Glazier R, McIsaac W, Smucny J. Antibiotics for acute bronchitis. In: The Cochrane Library, Issue 2, 1998. Oxford: Update software, search date 1997; primary sources Medline 1966 to 1996; Embase 1974.

    Fahey T, Stocks N, Thomas T. Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. Brit Med J 1998;316:906-10.

    Wark P. Bronchitis (acute). In: Clinical Evidence Concise. London. BMJ Publishing Group. 2004;11:362-63.

    Macfarlane J, Holmes W, Gard P, Thornhill D. Macfarlane R. Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trail of patient information leaflet. BMJ 2002;324:91-4.

    Treatment of cough available in Prodigy website: http://www.prodigy.nhs.uk/guidance.asp?gt=Sore%20throat%20-%20acute

    COPD

    Anthonisen MD, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Int Med 1987;106:196-204.

    Calverley PMA, Walker P. Chronic obstructive pulmonary disease. Lancet 2003;362:1053-61. Excellent review on pathophysiology and management of COPD. Little detailed information on antibiotic treatment.

    Chronic obstructive pulmonary disease. Management of COPD in adults in primary and secondary care. Clinical Guideline 12 February 2004. www.nice.org.uk/CG012NICEguideline

    Community-acquired pneumonia

    BTS guidelines for the management of community-acquired pneumonia in adults. Thorax 2001;56(Suppl 4):IV1-64.

    Hopstaken RM, Muris JWM, Knottnerus JA, Kester ADM, Rinkens PELM, Dinant GJ. Contributions of symptoms, signs, enthrocyte sedimentation rate and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Brit J Gen Pract 2003;53:358-364.

    Loeb M. Community-acquired pneumonia. In: Clinical Evidence Concise. London BMJ Publishing Group. 2004;11:364-66

    J T Macfarlane and D Boldy. 2004 update of BTS pneumonia guidelines: what’s new? Thorax 2004 May; 59(5): 634 - 6

     

    MENINGITIS

    Cartwright KAV, Strang J Gossain S, Begg N. Early treatment of meningococcal disease. Brit Med J 1992;305:774.

    Correla J & Hart CA. Meningococcal disease. In: Clinical Evidence Concise. London. BMJ Publishing Group. 2004;11:206-07.

    Pre-admission benzylpenicillin for suspected meningococcal disease: other antibiotics not needed in the GP bag. CDR Weekly 15 February 2001.

    PHLS Meningococcus Forum, endorsed by the PHLS, Public Health Medicine Environment Group and Scottish Centre for Infection and Environmental Health. Guidelines for public health management of meningococcal disease in the UK. Commun Dis Public Health 2002;5:187-204. http://www.hpa.org.uk/cdph/issues/CDPHVol5/no3/Meningococcal_Guidelines.pdf

     

    URINARY TRACT INFECTIONS

    Elderly

    Abrutyn E, Mossey J, Berlin JA, Boscia J, Levison M, Pitsakis P, Kaye D. Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women? Ann Int Med 1994:827-33.

    Nicholl LE. Urinary tract infection. In: Infection Management for Geriatrics in Long-term Care Facilities. Eds Yoshikawa TT, Ouslander JG. Marcel Dekker. New York. 2002:173-95.

    Carson C, Naber KG, Role of fluoroquinolones in the treatment od serious bacterial urinary tract infections. Drugs 2004; 64(12): 1359 - 73

    Uncomplicated UTI

    Charlton CAC, Crowther A, Davies JG, Dynes J, Howard MWA, Mann PG, Rye S. Three day and ten day chemotherapy for urinary tract infections in general practice. Brit Med J 1976;1:124-6.

    Christiaens TCM, Meyere M De, Vershcraegen G. Peersman W, Heytens S. Maeseneer JM De. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Brit J Gen Pract 2002;52:729-34.

    Davey PG, Steinke D. MacDonald TM, Phillips G, Sullivien F. Not so simple cystitis: How should prescribers be supported to make informed decisions about the increasing prevalence of infections caused by drug resistant bacteria? Brit J Gen Pract 2000;50:143-46.

    Ellis R & Moseley DJ. A comparison of amoxicillin, co-trimoxazole, nitrofurantoin, macrocrystals and trimethoprim in the treatment of lower urinary tract infections. Management of UTIs. Ed. LH Harrison. 1990. Royal Society of Medicine Services International Congress & Symposium Series No. 154, publishers RSM Services Ltd. pp 45-52.

    Gossius G Vorland L. The treatment of acute dysuria-frequency syndrome in adult women: double blind randomized comparison of three day versus ten day trimethoprim therapy. Curr Ther Res 1985;37(1):34-42.

    Guay DR. An update on the role of nitrofurans in the management of urinary tract infections. Drugs 2000;61:353-64.

    Hiscoke C, Yoxall H, Greig D, Lightfoot NF. Validation of a method for the rapid diagnosis of urinary tract infection suitable for use in general practice. Brit J Gen Pract 1990;40:403-5.

    Hummers-Pradier E. Kocken MM. Urinary tract infections in adult general practice patients. Brit J Gen Pract 2002;52:752-61.

    Livermore D, & Woodford N. Laboratory detection of bacteria with extended-spectrum beta-lactamases. CDR Weekly

    2004;14 No. 27.

    McCarty JM, Richard G, Huck W, Tucker RM, Toxiello RL, Shan M, Heyd A, Echols RM. A randomised trial of short-course ciprofloxacin, ofloxacin or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Am J Med 1999;106:292-9.

    UTI in pregnancy

    Information from the National Teratology Information Service (Tel: 0191 230 2036, Fax: 0191 232 7692) states:

    Trimethoprim is a folate antagonist. In some women low folate levels have been associated with an increased risk of malformations. However, in women with normal folate status, who are well nourished, therapeutic use of trimethoprim for a short period is unlikely to induce folate deficiency.

    A number of retrospective reviews and case reports indicate that there is no increased risk of foetal toxicity following exposure to nitrofurantoin during pregnancy. Serious adverse reactions eg peripheral neuropathy, severe hepatic damage and pulmonary fibrosis are extremely rare. Nitrofurantoin can cause haemolysis in patients with G6PD deficiency. Foetal erythrocytes have little reduced glutathione and there is a theoretical possibility that haemolysis may occur. However, haemolytic disease of the new-born has not been reported following in utero exposure to nitrofurantoin.

    Children

    Larcombe J. Urinary tract infections in children. In: Clinical Evidence Concise. London. BMJ Publishing Group 2004;11:87-90.

    Acute pyelonephritis

    Talan DA, Stamm WE, Hooton TM, Moran GJ, Burke T, Iravani A, Reuning-Scherer J and Church DA. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women. A randomized trial. JAMA 2000;283:1583-90. Evidence for 7 days ciprofloxacin.

    Warren JW, Abrutyn E. Hebel JR et al Guidelines for antimicrobial treatment of uncomplicated bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999;29:745-58.

     

    GASTRO-INTESTINAL TRACT INFECTIONS

    Eradication of Helicobacter pylori

    Bazzdi F. Pozzato P. Rokkas T. Helicobacter pylori: the challenge in therapy. Helicobacter 2002;7 (Suppl 1):43-49.

    British Society of Gastroenterology (1996) Dyspepsia Management Guidelines 1 pp1-8.

    de Boer WA, Tytgat GNJ. Treatment of Helicobacter pylori infection. Brit Med J 2000;320:31-4.

    Delaney B, Moayyedi P, Forman D. Helicobacter pylori infection. In: Clinical Evidence Concise. London. BMJ Publishing Group. 2004;11:107-09.

    NICE dyspepsia guidance. August 2004. Evidence indicates once daily PPI plus metronidazole 400mg BD + clarithromycin 250mg BD is as effective as using BD PPI or 500mg clarithromycin. This regimen is cheaper than using BD PPI or higher dose clarithromycin. http://www.nice.org.uk/pdf/CG017fullguideline.pdf

    Prodigy dyspepsia guidelines:

    http://www.prodigy.nhs.uk/guidance.asp?gt=Dyspepsia%20-%20proven%20DU%20or%20GU

    Gastroenteritis

    de Bruyn G. Diarrhoea. In: Clinical Evidence Concise. London. BMJ Publishing Group2004;11:187-88.

    Farthing M, Feldman R, Finch R, Fox R, Leen C, Mandal B, Moss P, Nathwani D, Nye F, Percival A, Read R, Ritchie L, Todd WT, Wood M. J of Infect 1996;33:143-52. The management of infective gastroenteritis in adults. A consensus statement by an expert panel convened by the British Society for the Study of Infection.

    Gastroenteritis guidance in Prodigy: http://www.prodigy.nhs.uk/guidance.asp?gt=Gastroenteritis

    Goodman LJ, Trenholme GM, Kaplan RL el al. Empiric antimicrobial therapy of domestically acquired acute diarrhoea in urban adults. Arch Intern Med 1990;150:541-6.

    Traveller’s diarrhoea

    What to do about Traveller’s diarrhoea. Drugs & Therapeutic Bulletin 2002;40:36-38.

     

    GENITAL TRACT INFECTIONS

    Epididymitis

    Hagley M. Epididymo-orchitis and epididymitis: a review of causes and managementof unusual forms. Int J STD AIDS. 2003 Jun; 14(6): 372 - 7

    General

    Joesoef MR & Schmid G. Bacterial vaginosis. In: Clinical Evidence Concise. London. BMJ Publishing Group. 2004;11:384-86

    Low N. Genital chlamydial infection. In: Clinical Evidence Concise. London. BMJ Publishing Group. 2004;11:387-89.

    Mitchell H. Vaginal discharge – causes, diagnosis and treatment. BMJ 2004;328:1306-08. Short review

    Ross JDC. Outpatient antibiotics for pelvic inflammatory disease. BMJ 2001;322:251-2.

    Sabbaj J, Hoagland VL, Cook T. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men. Scand J Infect Dis 1986;Suppl 48:48-53.

    Sexually Transmitted Infections 1999;75:Suppl 1. UK National Guidelines on Sexually Transmitted Infections and Closely Related Conditions. These guidelines are fully comprehensive and extensively referenced. Also available on the web. http://www.bashh.org/guidelines/ceguidelines.htm

    Walker CK, Workowski KA, Washington AE, Soper DE, Sweet RL. Anaerobes in pelvic inflammatory disease: implications for the Centers for Disease Control and preventions guidelines for treatment of sexually transmitted diseases. Clin Infect Dis 1999;28:529-36.

     

    SKIN/SOFT TISSUE INFECTIONS

    Impetigo

    Sladden MJ, Johnston GA. Common skin infections in children. BMJ. 2004 Jul 10; 329 (7457): 95-9

    Koning S, Verhagen AP, van Suijlekom-Smit LW, Morris A, Butler CC, van der Wouden JC. Interventions for impetigo. Cochrane database syst rev. 2004; (2):CD003261

    Smethurst D & Macfarlane S. Atopic eczema. In: Clinical Evidence. London. BMJ Publishing Group. Available on web only. http://127.0.0.1:49152/lpBinCE/lpext.dll?f=templates&fn=main-hit-h.htm&2.0

    George A, Rubin G. A systematic review and meta-analysis of treatments for impetigo. Brit J Gen Pract 2003;53:480-87. (No difference between topical mupirocin and fusidic acid, no significant difference between topical and oral).

    MeReC Bulletin. Acne. November 1994.

    Eczema

    Hoare C, Li Wan PA, Williams H (2000). Systematic review of treatments for atopic eczema. Health Technology Assessment 2000;4(37):1-191.

    Prodigy guidance – atopic eczema. http://www.prodigy.nhs.uk/guidance.asp?gt=Eczema%20-%20atopic#MI4_Infectedeczema

    Cellulitis

    Dilemmas when managing cellulitis. Drugs & Therapeutic Bulletin 2003;41:43-46. (Review of the management of cellulitis)

    Diabetic leg ulcer

    Jeffcoate WJ, Harding KG. Review: Diabetic foot ulcers. Lancet 2003;361:1545-51.

    Animal/human bites

    Anderson CR. Animal bites. Guidelines to current management. Postgraduate Medicine 1992;92:134-49.

    Goldstein EJC. Bites. In: Mandell GL, Bennett JE, Dolin R Eds. Principles and Practice of Infectious Diseases. Churchill Livingstone. 2000;2:3202-05.

    Jones DA & Standbridge TN. A clinical trial using co-trimoxazole in an attempt to reduce wound infection rates in dog bite wounds. Postgraduate Medical J 1985;61:593-4.

    Medeiros I, Saconat H. Antibiotic prophylaxis for mammalian bites (Cochrane Review). In: The Cochrane Library, Issue 2, 2001 Oxford: Update Software.

    Prodigy website guidance.

    http://www.prodigy.nhs.uk/guidance.asp?gt=Bites%20-%20human%20and%20animal#AntiobioticProphylaxis

    Conjunctivitis

    Smith J. Bacterial conjunctivitis. In: Clinical Evidence Concise. London. BMJ Publishing Group. 2004;11:156.Scabies

    The management of scabies. Drug & Therapeutics Bulletin 2002;40:43-46

    Walker G, Johnstone P. Scabies. Clin Evid 2003 Dec;(10): 1910 - 8

    Dermatophytes

    Crawford F. Athlete’s foot and fungally infected toenails. In: Clinical Evidence Concise. London. BMJ Publishing Group. 2004;11:403

    Evans EGV & Sigurgeirsson B for the LION Study Group. Double blind randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. Brit Med J 1999;318:1031-5.

    Finlay AY. Skin and nail fungi – almost beaten. Don’t get confused by the ‘evidence’. Brit Med J 1999;319:71-2.

    Fuller LC, Child FJ, Midgley G, Higgins EM. Diagnosis and management of scalp ringworm. BMJ 2004;326:539-41.

    Getting rid of athlete’s foot. Drug & Therapeutics Bulletin 2002;40:53-54.

    Hart R, Bell-Syer SEM, Crawford F, Torgerson DJ, Young P, Russell I. Systematic review of topical treatments for fungal infections of the skin and nails of the feet. Brit Med J 1999;319:79-82.

    Chickenpox/shingles

    Dunkle LM, Arvin AM, Whitley RJ, Rotbart HA, Feder HM, Feldman S et al. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med 1991;325:1539-44.

    Johnson RW.Herpes zoster – predicting and minimizing the impact of post-herpatic neuralgia. J Antimicrob Chemother 2001;47:Topic T11-8.

    McKendrick MW & Balfour HH Jr. Acyclovir for childhood chickenpox. Controversies in management. Brit Med J 1995;310:108-110.

    Prodigy Guidance – Shingles & postherpetic neuralgia. April 2002. At www.prodigy.nhs.uk and go to guidance list.

    Swingler G. Chicken Pox. In: Clinical Evidence Concise. London. BMJ Publishing Group. 2004;11:180-82.

    Wareham D. Post herpetic neuralgia. In: Clinical Evidence Concise. London. BMJ Publishing Group. 2004;11:208-10.